Prognostic factors related to add-on dendritic cell vaccines on patients with inoperable pancreatic cancer receiving chemotherapy: a multicenter analysis-Reference-Cited by-同舟云学术

Prognostic factors related to add-on dendritic cell vaccines on patients with inoperable pancreatic cancer receiving chemotherapy: a multicenter analysis

Published:2014-04-29 Issue:8 Volume:63 Page:797-806
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Kobayashi Masanori, ,Shimodaira Shigetaka,Nagai Kazuhiro,Ogasawara Masahiro,Takahashi Hidenori,Abe Hirofumi,Tanii Mitsugu,Okamoto Masato,Tsujitani Sun-ichi,Yusa Seiichi,Ishidao Takefumi,Kishimoto Junji,Shibamoto Yuta,Nagaya Masaki,Yonemitsu Yoshikazu

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-014-1554-7.pdf

Reference36 articles.

1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277–300

2. Wada K, Takaori K, Traverso LW, Hruban RH, Furukawa T, Brentnall TA et al (2013) Clinical importance of familial pancreatic cancer registry in Japan: a report from kick-off meeting at international symposium on pancreas cancer 2012. J Hepatobiliary Pancreat Sci 20:557–566

3. Cleary SP, Gryfe R, Guindi M, Greig P, Smith L, Mackenzie R et al (2004) Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg 198:722–731

4. Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR et al (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403–2413

5. Ueno H, Ioka T, Ikeda M, Ohkawa S, Yanagimoto H, Boku N et al (2013) Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: gEST Study. J Clin Oncol 31:1640–1648

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Tumor Microenvironment in Pancreatic Cancer Immunotherapy: Current Status and Future Perspectives;International Journal of Molecular Sciences;2024-09-03

2. Developing Vaccines in Pancreatic Adenocarcinoma: Trials and Tribulations;Current Oncology;2024-08-23

3. Current and future immunotherapeutic approaches in pancreatic cancer treatment;Journal of Hematology & Oncology;2024-06-04

4. Dendritic cell vaccination in combination with erlotinib in a patient with inoperable lung adenocarcinoma: a case report;Journal of Medical Case Reports;2024-02-10

5. Attitudes, expectations, and lived experiences of cancer patients receiving dendritic cell vaccine therapy in Japan;Asia-Pacific Journal of Oncology Nursing;2023-12